Skip to main content
Sirona Biochem Corp. logo

Sirona Biochem Corp. — Investor Relations & Filings

Ticker · SRBCF ISIN · CA82967M1005 LEI · 549300CQE1Q87IG6W210 TSXV Real estate activities
Open in API
Filings indexed 367 across all filing types
Latest filing 2023-02-27 Regulatory Filings
Country CA Canada
Listing TSXV SRBCF

About Sirona Biochem Corp.

https://www.sironabiochem.com/

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery firm utilizing a proprietary platform technology to develop novel compounds. Through its wholly-owned French subsidiary, TFChem, the company specializes in stabilizing carbohydrate molecules, often via fluorination chemistry, to enhance their efficacy and safety for medical and cosmetic applications. Sirona Biochem's business strategy involves licensing or selling its patented compounds, such as the anti-aging and anti-wrinkle molecule GlycoProteMim™ (TFC-1326), to leading global pharmaceutical and cosmetic companies in exchange for up-front fees, milestone payments, and ongoing royalties.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of antiviral testing results from a research collaboration. It contains no financial statements, regulatory form references, or detailed financial data. It is a corporate announcement about scientific progress and research results, not a financial report or regulatory filing. The document length is moderate (6174 characters), but the content is clearly a news announcement rather than a report or filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2023-02-27 English
News release - English.pdf
Regulatory Filings
2023-01-16 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release announcing the voting results from the Annual General Meeting (AGM) of Sirona Biochem Corp. It details the shareholder votes on board election, auditor appointment, and stock option plan approval. The document is short (3781 characters) and focuses solely on the announcement of voting results, not the full AGM materials or presentations. It does not contain financial statements or detailed report content. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-12-30 English
Management information circular - English.pdf
Regulatory Filings
2022-12-08 English
News release - English.pdf
Regulatory Filings
2022-12-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a research collaboration agreement between Sirona Biochem and the International Centre for Genetic Engineering and Biotechnology (ICGEB). It discusses the purpose and scope of the collaboration, the institutions involved, and the expected timeline for initial evaluation. There is no financial data, regulatory filing references, or detailed financial performance information. The document is an announcement of a corporate development rather than a financial report, regulatory filing, or management discussion. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not related to board changes, voting results, or capital changes. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2022-11-10 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.